The BR serine/threonine kinase 2 has been identified as a target autoantigen in limbic encephalitis and small cell lung carcinoma [26] and the adenylate kinase 5 has been found in patients with autoimmune encephalitis without known cancer [23]. Here, AK5 is linked to small cell lung carcinoma.